// Daily US stock report
October 26, 2026
Premarket and post-market candidates with catalyst context and Trend Join Long scanner decisions.
04:00-09:30 ET
Premarket Scan
08:49 ET scan: 4 candidates were checked. None passed both trend conditions.
| Symbol | Market cap | Premarket price | Gap | Premarket volume | 20-day average volume | Premarket / average | What probably caused it | Why it fit the premarket candidate filter | Why it fit the trend scanner report or failed to fit the trend scanner |
|---|---|---|---|---|---|---|---|---|---|
| XNCR | $1.87B | $33.260 | +32.09% | 690,804 | 1,382,194 | 49.98% | Xencor reported updated Phase 1 XmAb819 data in advanced clear cell renal cell carcinoma, including a 45.5% confirmed response rate at the selected dose and plans to discuss a potential accelerated-approval pathway with the FDA. Confirmed catalyst. | At the candidate scan it had a $1.87B market cap, a $33.260 premarket price, a 32.09% gap, 690,804 premarket shares, and premarket volume equal to 49.98% of its 20-day average. | fail_intraday. curr_px 33.750 > prev_daily_high 25.810 and prev_daily_close 25.180 > SMA200 16.568275, but curr_px 33.750 <= premarket high 35.590. |
| SGRY | $2.06B | $19.500 | +23.81% | 91,680 | 1,761,183 | 5.21% | No reliable fresh catalyst was found. Surgery Partners' official news page showed no same-day announcement; its latest listed release was the September 17 completion of an Idaho Falls facility-interest sale. No confirmed catalyst. | At the candidate scan it had a $2.06B market cap, a $19.500 premarket price, a 23.81% gap, 91,680 premarket shares, and premarket volume equal to 5.21% of its 20-day average. | insufficient_data. The latest premarket quote was timestamped 08:14:51 ET and was about 34 minutes old. Reference comparisons: 19.500 > prev_daily_high 16.160, prev_daily_close 15.750 > SMA200 14.443850, and 19.500 <= premarket high 19.710. |
| RRC | $10.64B | $49.927 | +9.68% | 192,492 | 2,710,005 | 7.10% | EQT announced an all-stock acquisition of Range Resources. Each Range share is to receive 0.987 EQT shares, with Range shareholders expected to own about 27% of the combined company. Confirmed catalyst. | At the candidate scan it had a $10.64B market cap, a $49.927 premarket price, a 9.68% gap, 192,492 premarket shares, and premarket volume equal to 7.10% of its 20-day average. | fail_intraday. curr_px 50.670 > prev_daily_high 45.735 and prev_daily_close 45.520 > SMA200 39.879100, but curr_px 50.670 <= premarket high 53.000. |
| HSAI | $2.06B | $13.810 | +5.18% | 73,639 | 1,631,894 | 4.51% | No reliable fresh catalyst was found. Hesai's official investor-relations page showed no same-day release; its latest listed update was the October 20 scheduling of third-quarter results for November 10. No confirmed catalyst. | At the candidate scan it had a $2.06B market cap, a $13.810 premarket price, a 5.18% gap, 73,639 premarket shares, and premarket volume equal to 4.51% of its 20-day average. | fail_daily. curr_px 13.880 > prev_daily_high 13.310, but prev_daily_close 13.130 <= SMA200 20.189900; curr_px 13.880 <= premarket high 14.180. |
Average volume is the mean regular-session volume over the latest 20 completed trading days. Higher relative volume indicates stronger participation, but it does not prove that a breakout is real or durable.
09:30-20:00 ET
Regular + Post-market Scan
Pending 20:45 ET evening scan. The post-market section will be completed after the extended-hours session ends.
Research only. This is not investment advice, and no trade is placed by either scanner.